v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Sep. 30, 2021
Current Assets    
Cash and cash equivalents $ 444.8 $ 446.1
Trade receivables, net 306.0 323.5
Receivables from long-term manufacturing contracts, net 173.5 121.9
Inventories, net 481.2 411.6
Prepaid expenses and other current assets 104.5 75.2
Current assets held for sale 0.0 56.2
Total current assets 1,510.0 1,434.5
Property, plant, and equipment, net 281.3 295.1
Operating lease right-of-use assets, net 136.0 138.1
Intangible assets, net 885.1 913.9
Goodwill 1,159.9 1,168.6
Other long-term assets 92.7 64.7
Total Assets 4,065.0 4,014.9
Current Liabilities    
Trade accounts payable 428.4 361.3
Liabilities from long-term manufacturing contracts and advances 299.9 296.6
Current portion of long-term debt 0.0 0.0
Accrued compensation 99.9 123.5
Current liabilities held for sale 0.0 18.9
Other current liabilities 246.1 234.8
Total current liabilities 1,074.3 1,035.1
Long-term debt 1,214.0 1,212.9
Accrued pension and postretirement healthcare 142.6 151.6
Operating lease liabilities 104.4 105.6
Deferred income taxes 190.7 206.7
Other long-term liabilities 61.2 70.8
Total Liabilities 2,787.2 2,782.7
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 72.4 and 72.7 shares outstanding) 0.0 0.0
Additional paid-in capital 717.3 725.4
Retained earnings 737.1 666.2
Treasury stock (3.4 and 3.1 shares, at cost) (152.2) (135.7)
Accumulated other comprehensive loss (47.7) (46.3)
Hillenbrand Shareholders’ Equity 1,254.5 1,209.6
Noncontrolling interests 23.3 22.6
Total Shareholders’ Equity 1,277.8 1,232.2
Total Liabilities and Shareholders’ Equity $ 4,065.0 $ 4,014.9

Source